Flounder Pharmaceuticals Private Limited
About Flounder Pharmaceuticals Private Limited
Data last updated:
Flounder Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 04 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2012PTC048205. Its GSTIN is 09AABCF8730A1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Soni (Whole-Time Director) and Santosh Soni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 268 Prabhu Sadan Narkulaganj Nai Basti, Bareilly, Uttar Pradesh, India – 243005.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.26 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4.03 Lakh (net margin -39.3%) and EBITDA of -₹3.74 Lakh (EBITDA margin -36.4%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Flounder Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address268 Prabhu Sadan Narkulaganj Nai Basti, Bareilly, Uttar Pradesh, India – 243005
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Flounder Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Flounder Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Flounder Pharmaceuticals Private Limited, buy the company report.
Financials of Flounder Pharmaceuticals Private Limited
FY 2023 filings availableFlounder Pharmaceuticals Private Limited reported revenue of ₹10.26 Lakh (up 209% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 209% growth in the latest year. EBITDA fell 229% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -36.4% | ||||
| Net Profit Margin | -39.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Flounder Pharmaceuticals Private Limited, buy the company report.
Board of directors of Flounder Pharmaceuticals Private Limited
Flounder Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Soni | Whole-Time Director | 04 Jan 2012 | 14 Years 9 Months | Current |
| Santosh Soni | Whole-Time Director | 04 Jan 2012 | 14 Years 9 Months | Current |
Peer comparison
Flounder Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cosy Pharmaceuticals Private Limited | ₹10.3 Lakh (FY 2025) | -20.0% | Uttar Pradesh, India | |||
| Iesa Pharmaceuticals Private Limited | ₹10.29 Lakh (FY 2025) | 77.0% | Lucknow, Uttar Pradesh, India | |||
| Himabhoomi Pharmaceuticals Private Limited | ₹10.27 Lakh (FY 2018) | 22.0% | Hyderabad, Telangana, India | |||
| Flounder Pharmaceuticals Private Limitedthis company | ₹10.26 Lakh (FY 2023) | -₹4.03 Lakh | -39.3% | 209.0% | Bareilly, Uttar Pradesh, India | |
| Wana Pharmaceuticals Private Limited | ₹10.21 Lakh (FY 2021) | Sahibabad, Uttar Pradesh, India | ||||
| Pamasha Pharmaceuticals Private Limited | ₹10.2 Lakh (FY 2025) | 187.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Flounder Pharmaceuticals Private Limited, buy the company report.
Auditor
Flounder Pharmaceuticals Private Limited is audited by VISHAL RAMESH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHAL RAMESH & ASSOCIATES | FY 2017 | 403373 |
Shareholding
The shareholding of Flounder Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Flounder Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Flounder Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Flounder Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Flounder Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCF8730A1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Flounder Pharmaceuticals Private Limited, buy the company report.
Recent activity
Flounder Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Prashant Soni was appointed as Whole-Time Director on 04 Jan 2012.
Frequently asked questions
Flounder Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 04 January 2012 (14+ years old) and is registered under CIN U24233UP2012PTC048205.
Flounder Pharmaceuticals has 2 current directors:
- Prashant Soni - Whole-Time Director
- Santosh Soni - Whole-Time Director
The latest financial statements of Flounder Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Flounder Pharmaceuticals is 09AABCF8730A1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Flounder Pharmaceuticals is U24233UP2012PTC048205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Flounder Pharmaceuticals was incorporated on 04 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Flounder Pharmaceuticals by revenue are Cosy Pharmaceuticals Private Limited, Iesa Pharmaceuticals Private Limited, Himabhoomi Pharmaceuticals Private Limited, Wana Pharmaceuticals Private Limited, Pamasha Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prashant Soni was appointed as Whole-Time Director on 04 Jan 2012. Santosh Soni was appointed as Whole-Time Director on 04 Jan 2012.
The registered office of Flounder Pharmaceuticals is at 268 Prabhu Sadan Narkulaganj Nai Basti, Bareilly, Uttar Pradesh, India – 243005.
Flounder Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Flounder Pharmaceuticals is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.